CIDRAP newsletters options
(CIDRAP News) Public health officials in two countries today announced new human cases of H5N1 avian influenza, involving a 19-year-old Chinese woman who died of her infection and an 8-year-old Vietnamese girl who is recovering.
(CIDRAP News) The World Health Organization (WHO) recently reported that laboratory officials in the Democratic Republic of the Congo (DRC) have confirmed a third case of Ebola hemorrhagic fever.
Laboratory analysis was performed at the DRC's national lab in Kinshasa, a lab in Franceville, Gabon, and at the National Institute for Communicable Diseases in South Africa, according to a Jan 2 statement from the WHO.
(CIDRAP News) Animal health officials in India's West Bengal state recently reported new H5N1 avian influenza outbreaks in two more districts, according to media reports.
(CIDRAP News) A newly published analysis of oseltamivir-resistant influenza viruses collected last winter in Norway hints that they may increase an infected person's risk of pneumonia and sinus infections, but the small number of patients in the study means the finding is no more than a hint at this point.
Dec 30. 2008 (CIDRAP News) Health officials in Hong Kong today said a 2-month-old girl who lives in mainland China has been hospitalized at a Hong Kong hospital for an H9N2 avian influenza infection, which typically causes mild illness but is considered one of the viruses that could evolve into a pandemic strain.
Editor's note: This story was revised Dec 30 to make clear that as of Dec 29, only two cases in the outbreak had been confirmed as Ebola. During the DRC's 2007 outbreak the government confirmed 17 cases, down from 25 it reported earlier, and initial reports during that outbreak mentioned as many as 395 suspected Ebola cases. Some of the suspected patients had other diseases, including shigellosis.
(CIDRAP News) While the US influenza season has started slowly, cases are surging in England, raising concern that the country could have its toughest season since 1999-2000.
(CIDRAP News) Agriculture officials in Bangladesh said today that they have detected another H5N1 avian influenza outbreak on a farm, the country's fifth one since the virus reemerged in poultry flocks in October.
(CIDRAP News) – The US Food and Drug Administration (FDA) recently approved a new version of BioThrax—the nation's only licensed anthrax vaccine—that requires fewer doses and changes the injection route.
(CIDRAP News) – An H5N1 influenza vaccine made by Baxter International could become the first cell culture–based H5N1 influenza vaccine to be approved for marketing, following its endorsement by a committee of the European Medicines Agency (EMEA) last week.
Recommendations of the Committee for Medicinal Products for Human Use (CHMP) are usually followed by the EMEA within a few months.
(CIDRAP News) Increased resistance to oseltamivir (Tamiflu), the leading influenza drug, has prompted federal health officials to change their advice about flu treatment, saying clinicians for now should consider using zanamivir (Relenza) or a combination of two drugs for patients suspected of having influenza A.
(CIDRAP News) – Authorities from Cambodia, Bangladesh, and Egypt reported that the H5N1 avian influenza virus has struck poultry again, according to new reports.
(CIDRAP News) Cost issues and the risk of viral resistance drew considerable attention today in an online presentation by federal health officials on their revised guidance regarding use of antiviral drugs in an influenza pandemic.
The Department of Health and Human Services (HHS) released two guidance documents this week, one on antiviral use in general and one on employer stockpiling of antivirals.
(CIDRAP News) Egypt's health ministry has announced that a 16-year-old girl died of an H5N1 avian influenza infection, the country's first human case in about 8 months, according to a report today from the World Health Organization (WHO).
Editor's note: This story was revised Dec 17 to include an item that was mistakenly left out of the list of five main recommendations on antiviral use in a pandemic.
(CIDRAP News) – China's agriculture ministry today said it has detected H5N1 avian influenza outbreaks at two poultry farms in Jiangsu province in the eastern part of the country.
In a statement posted on its Web site, the ministry said both sites where the H5N1 virus was found are in Haian county, in the eastern part of the province, according to a report today from Agence France-Presse (AFP).
(CIDRAP News) A World Health Organization (WHO) group that met last week in Geneva to solve problems related to global sharing of H5N1 avian influenza viruses made progress on language spelling out the commitment to sharing both the viruses and benefits, a senior US government official told CIDRAP News.
(CIDRAP News) The World Health Organization (WHO) today reported that a 19-year-old man from Cambodia has been hospitalized with H5N1 avian influenza, the country's first case in nearly a year and a half.
The man, from Kandal province, got sick on Nov 28 and first sought care from his local health center 2 day later, according to the WHO report. He is now listed as Cambodia's eighth H5N1 case, of which seven have been fatal.
(CIDRAP News) With this year's US influenza epidemic barely getting started, there are already signs of increased viral resistance to oseltamivir (Tamiflu), the most widely used antiviral drug, the Centers for Disease Control and Prevention (CDC) said today.
In its flu surveillance report for Nov 30 to Dec 6, released today, the CDC said 45 of 46 influenza A/H1N1 viruses tested so far have shown resistance to oseltamivir.
(CIDRAP News) Half-dose influenza shots generate nearly as strong an immune response in young adults as full-dose shots do, suggesting that cutting the dose in half may be a good way to cope with vaccine shortages, according to a study published this week.